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ABSTRACT
Introduction: During the first pandemic wave of the influenza A H1N1 2009 virus, morbidity 
was particularly high in Brazil. Hospitalizations resulting from severe respiratory disease due 
to suspected influenza-like illness created an opportunity to identify other respiratory viruses 
causing lower respiratory infections. Objective: The purpose of this study was to assess viral 
etiologies among samples collected during the first pandemic wave of H1N1 2009 from hos-
pitalized patients with suspected cases in a Brazilian Sentinel Hospital. Patients and methods: 
Viral etiologies were investigated in samples from 98 children and 61 adults with fever, cough 
and dyspnea who were admitted to São Paulo Sentinel Hospital with suspected H1N1 infection. 
Results: From August to November 2009, in 19.5% (31/159) of the samples 2009 H1N1 virus 
was detected with 23% (14/61) in adults (median age 25 years, range: 14-55 years) and 18.4% 
(17/92) in children (median age 5 years, range: 4 months - 11 years). Among the negative sam-
ples, a wide range of causative etiologic agents was identified. Human rhinovirus was the most 
frequent virus (23.91%) in children and human metapneumovirus (11.48%) was the second 
most frequent in adults, following 2009 H1N1 virus (22.95%). Conclusions: These data high-
light the need to diagnose other viral infections that can co-circulate with influenza and may 
have been neglected by physicians as causes of severe respiratory diseases.
Keywords: influenza virus; influenza A H1N1 2009 virus; rhinovirus; human metapneumovi-
rus; human respiratory syncytial virus; respiratory viruses.
[Braz J Infect Dis 2011;15(3):220-224]©Elsevier Editora Ltda.
INTRODUCTION
In April 2009, a novel variant of influenza 
virus (2009) H1N1 of swine origin appeared 
and spread rapidly worldwide. On June 11, 
the World Health Organization (WHO) 
raised its pandemic alert to the highest lev-
el, phase 6.1 The morbidity and mortality of 
2009 H1N1 virus were particularly high in 
Brazil during the first pandemic wave on the 
southern hemisphere.2 The pandemic stage 
resulted in increased surveillance and sam-
pling, school closings and other measures 
for pandemic control.2,3 In addition, hospi-
talized cases4 of 2009 H1N1 virus resulted 
in increased demand for health care. Severe 
respiratory disease hospitalizations due to 
suspected influenza-like illness created an 
opportunity to identify other respiratory 
viruses causing lower respiratory infections.
OBJECTIVE
The purpose of this study was to assess vi-
ral etiologies among the samples collected 
from hospitalized patients with suspected 
influenza during the first pandemic wave 
of influenza A H1N1 2009 virus in a Brazil-
ian Sentinel Hospital.
PATIENTS AND METHODS
Sample collection
From August 19 to November 30, 2009 
(epidemiological week 34 to 43), a total of 
159 nasal/throat swab samples (one sample 
per patient) were collected from patients 
at São Paulo Hospital, São Paulo, Brazil. 
Patient inclusion criteria followed the Na-
tional Program Protocol: clinical suspicion 
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of potentially severe influenza A H1N1 2009 virus infec-
tion defined as fever, cough and dyspnea. 
From August to November 2009, the peak of the first 
pandemic wave in São Paulo, a single sample from each of 
159 hospitalized patients (98 children and 61 adults) was 
tested in the clinical virology laboratory. This study 
was approved by the Ethics Committee of Universidade 
Federal de São Paulo.
Viral total-RNA extraction
Viral RNA and DNA were extracted from 200 µL of each 
clinical specimen using the RTP DNA/RNA Virus Mini-
Kit (Invitek, Germany) according to the manufacturer’s 
instructions.
Molecular diagnostics
Detection of influenza A seasonal (IAV) and H1N1 2009 vi-
ruses was performed according to the Real Time protocol pub-
lished by the CDC on April 28, 2009.5 After excluding influenza 
A infection (H1N1 2009 and seasonal influenza), the negative 
samples were tested for the presence of the following viruses 
as described previously: seasonal influenza virus B (IBV) with 
primers targeting the NS gene,6 human rhinovirus (HRV) with 
primers targeting the 5’NCR and VP4/VP2 genes,7 human 
metapneumovirus (hMPV) with primers targeting the fusion 
protein gene,8 adenovirus (AdV) with primers targeting the 
hexon gene9 and human respiratory syncytial virus (HRSV) 
with primers targeting the fusion protein gene.10 The eluted 
RNA was transcribed into cDNA by moloney murine reverse 
transcriptase (MMLV-RT; Invitrogen, Carlsbad, CA) using 
random primers (Invitrogen, Carlsbad, CA) for 1 h at 37°C. The 
MMLV-RT was subsequently denatured at 70°C. The cDNA 
was amplified with virus-specific oligonucleotide primers and 
Platinum Taq DNA Polymerase (Invitrogen, Carlsbad, CA). All 
PCR parameters are shown in Table 1.
Seasonal IAV typing
Positive samples identified utilizing the Centers for Dis-
ease Control and Prevention (CDC) protocol for seasonal 
IAV were also tested using an in-house RT-PCR reaction 
followed by restriction fragment length polymorphism 
(RFLP) analysis. This method was performed as described 
previously11 and discriminates seasonal IAV H3N2 from 
seasonal IAV H1N1.
Statistical analysis
We evaluated viral infections in adult and child populations 
using the Chi-squared test (SPSS v11.5).
RESULTS
We studied 159 hospitalized patients: 61 adults, median age 
32 years (13 - 91 years), and 98 children, median age 2 years 
(2 days - 11 years); 97/159 (61%) tested positive for at least 
one virus, and 6/159 (3.77%) were coinfected with multiple 
viruses. Overall, 64.78% (103/159) of the viral etiologies 
were characterized. Patient samples were examined accord-
ing to age group (Figure 1). Children (≤ 12 years old) had 
a significantly higher frequency (67/92; 73%) of identified 
etiology when compared to adults (30/61; 49%) (p = 0.0021). 
Influenza: 31/159 (19.5%) samples tested were positive 
for influenza A H1N1 2009 virus, 14/61 (23%) adults and 
17/98 (17.3%) children. Only 10/159 (6.29%) samples were 
positive for seasonal IAV. None of the samples studied 
were positive for IBV. The median age of patients with influ-
enza A H1N1 2009 virus was 25 years (14 - 55 years) in adults 
and 5 years (4 months - 11 years) in children. Among the 10 
seasonal IAV positive samples (median age 7 years old, range: 
6 months - 51 years), 2 (20%) were characterized as H1N1, 
and the remaining 8 (80%) were characterized as H3N2. 
Other respiratory viruses were detected in 62/118 
(52.54%) samples that were negative for influenza A. Of 
those, 27 (22.88%) tested positive for HRV, 24 (20.34%) for 
hMPV, 3 (2.54%) for AdV and 2 (1.69%) for HRSV. HRV 
was the most frequently detected virus in children (23.91%), 
and hMPV (11.48%) was the second most frequently detect-
ed virus in adults, following 2009 H1N1 virus. Six specimens 
(6/118 - 5.08%) presented with coinfections with 2 viruses (4 
HRV/hMPV, 1 Adv/HRSV and 1 AdV/HRV). The median age 
of coinfected patients was 1.79 years (range: 1 month - 7 years).
The etiology of viral diagnoses over the course of the 
study (as a function of time in “weeks”) is shown in Figure 2. 
H1N1 virus was the most frequently detected infection (30% 
positivity) during the peak of the pandemic in São Paulo 
City (August 2009: 34 and 35 weeks; Figure 1), coincident 
with the beginning of the school calendar. HMPV was also 
observed at this time, and HRV was observed frequently 
throughout the study period. 
DISCUSSION
The emergence of a new pandemic influenza A lineage has 
led to an increase in surveillance of respiratory infections 
as well as hospitalizations and detection of other viruses.3
Here, we characterized the viral etiologies in two thirds 
of the patient samples. Higher detection rates could be 
achieved if others etiologies were investigated, such as atypi-
cal bacterial pneumonias. 
In agreement with other reports, our study demon-
strated that children had a higher frequency of identifiable 
etiology when compared to adults, and this was likely in-
fluenced by the high viral load present in these patients.12 
Additionally, it is likely that the national protocol guid-
ance13 calling for hospitalization of all symptomatic chil-
dren less than 2 years old with an acute respiratory infec-
tion influenced these results. 
The HRV was frequently associated with childhood hos-
pitalization in our study. Wheezing is a frequent clinical 
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Table 1. PCR parameters
                           Viruses
 Reagents  
 (volume/final IBV HRV hMPV HRSV AdV 
 concentration)
Reverse 
Buffer 5X 4 µL/1 X 4 µL/1 X 4 µL/1 X 4 µL/1 X - 
transcription
 DTT 2 µL/0.1 M 2 µL/0.1 M 2 µL/0.1 M 2 µL/0.1 M -
 dNTP 1 µL/1.0 mM 1 µL/1.0 mM 1 µL/1.0 mM 1 µL/1.0 mM -
 Random primer 1 µL/75 ng 1 µL/75ng 1 µL/75 ng 1 µL/75 ng -
 RNaseOUT 0.5 µL/20 U 0.5 µL/20 U 0.5 µL/20 U 0.5 µL/20 U -
 MMLV 0.5 µL/100 U 0.5 µL/100 U 0.5 µL/100 U 0.5 µL/100 U -
 DEPC water 6 µL 6 µL 6 µL 6 µL -
 RNA 5 µL 10 µL 5 µL 5 µL -
PCR Buffer 10X 2.5 µL/1 X 2.5 µL/1 X 2.5 µL/1 X 2.5 µL/1 X 2.5 µL/1 X
 MgCl2 1.25 µL/ 2.5 mM 1.75 µL/ 3.5 mM 2.0 µL/ 3.0 mM 1.75 µL/ 3.5 mM 1.5 µL/3.0 mM
 dNTP 1 µL/ 0.8 mM 1 µL/ 0.8 mM 1 µL/ 0.8 mM 1 µL/ 0.8 mM 1 µL/ 0.8 mM
 Primer forward 1 µL/ 0.4 mM 1 µL/ 0.4 mM 1 µL/ 0.4 mM 1 µL/ 0.4 mM 1 µL/ 0.4 mM
 Primer reverse 1 µL/ 0.4 mM 1 µL/ 0.4 mM 1 µL/ 0.4 mM 1 µL/ 0.4 mM 1 µL/ 0.4 mM
 Taq polymerase 0.5 µL/2.5 U 0.5 µL/2.5 U 0.5 µL/2.5 U 0.5 µL/2.5 U 0.5 µL/2.5 U
 DEPC water 12.75 µL 12.25 µL 12 µL 12.25 µL 12.5 µL
 cDNA/DNA 5 µL 5 µL 5 µL 5 µL 5 µL
Nested PCR Buffer 10X - - - - 2.5 µL/1 X
 MgCl2 - - - - 1.5 µL/3.0 mM
 dNTP - - - - 1 µL/0.8 mM
 Primer forward - - - - 1 µL/0.4 mM
 Primer reverse - - - - 1 µL/0.4 mM
 Taq polymerase - - - - 0.5 µL/2.5 U
 DEPC water - - - - 12.5 µL
 cDNA/DNA - - - - 2 µL
DTT, dithiothreitol; dNTP, deoxynucleotides; MMLV, moloney murine leukemia virus reverse transcriptase; DEPC, diethyl pyro-
carbonate; IBV, influenza B virus; HRV, human rhinovirus; hMPV, human metapneumovirus; HRSV, human respiratory syncytial 
virus; AdV, adenovirus.
Viral etiology in influenza A H1N1 2009 negative samples
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Figure 1: Viral etiology by age group of hospitalized patients during the 2009 pandemic.
Figure 2: Viral etiology of hospitalized patients during 2009 pandemic weeks 34-44.
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presentation in the emergency room that is possibly related 
to HRV infection,14 but we report here that it was misdiag-
nosed as H1N1 virus infection during the pandemic wave. 
In Thailand15 and Egypt,16 hMPV has been reported to be 
a community-acquired infection in patients presenting with 
pneumonia. However, the elevated rate of infection among 
non-elderly hospitalized adults was previously unreported in 
Brazil. This points to the severity of respiratory disease related to 
this virus, and indicates that it may be responsible for a greater 
portion of disease than previously suspected by physicians.15,17 
We observed a low rate of coinfection (3.77%) that ap-
peared exclusively in young children (median age 1.79 years 
old), in agreement with others reports.15 
H1N1 2009 virus infected children were older (5 years) 
than H1N1 negative children (median age 1 year old), in 
accordance with other studies.2,14,18 Pandemic influenza oc-
curred in young adults (25 years old), as previously de-
scribed.2,14,18 These data will contribute to the growing body 
of knowledge regarding influenza clinical management and 
immunization programs. 
H1N1 2009 was the most prevalent virus worldwide dur-
ing our expected influenza season, from June to September,19,20 
and this delayed seasonal H3N2 circulation until October and 
early November, extending the influenza season. 
Other viral etiologies accounting for increased health 
care demands and hospitalizations during the first wave of 
H1N1 2009 virus were underdiagnosed by physicians. It is 
likely that these account for an overestimation in influenza 
infection rates and may have resulted in inappropriate anti-
biotic prescriptions in unconfirmed cases.2,14
This study highlights the relevance and impact of both 
novel and established respiratory viruses that are respon-
sible for lower respiratory tract infections in adults and 
suggests the need to maintain surveillance during non-
pandemic periods. 
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